To assess the efficacy and safety of Saccharomyces boulardii combined with triple therapy containing minocycline in the initial eradication of Helicobacter pylori (H. pylori) infection
Aged 18-70 years, regardless of gender;
Positive 13C/14C urea breath test result;
No previous history of H. pylori eradication treatment;
Agreement to participate in this study and signing of the informed consent form.
History of ≥ 1 instance of failed H. pylori eradication;
Use of antibiotics (including antibacterial traditional Chinese medicines), nonsteroidal anti-inflammatory drugs (NSAIDS), bismuth agents, H2 receptor antagonists (H2RAs), proton-pump inhibitors (PPIs), and potassium-competitive acid blockers (P-CAB) within 4 weeks before treatment;
Plans to conceive, pregnancy, or breastfeeding;
Severe liver, kidney, or cardiovascular diseases; malignancies; and alcoholism;